BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26576938)

  • 1. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
    Hiraga T; Ito S; Nakamura H
    Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
    Hiraga T; Ito S; Nakamura H
    Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
    Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
    Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
    J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
    Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
    PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
    Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
    Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
    Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
    PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
    Huber S; Wege AK; Bernhardt G; Buschauer A; Brockhoff G
    Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpCAM expression in the prostate cancer makes the difference in the response to growth factors.
    Yoshida GJ; Saya H
    Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
    Martowicz A; Spizzo G; Gastl G; Untergasser G
    BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs.
    Liu L; Yin B; Yi Z; Liu X; Hu Z; Gao W; Yu H; Li Q
    Breast Cancer; 2018 Nov; 25(6):706-716. PubMed ID: 29948958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.
    Motohara T; Masuko S; Ishimoto T; Yae T; Onishi N; Muraguchi T; Hirao A; Matsuzaki Y; Tashiro H; Katabuchi H; Saya H; Nagano O
    Carcinogenesis; 2011 Nov; 32(11):1597-606. PubMed ID: 21828057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.